StockNews.AI
HUM
StockNews.AI
12 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM

1. Pomerantz LLP is investigating claims against Humana for potential securities fraud. 2. The DOJ has filed a False Claims Act lawsuit involving Humana's business practices. 3. Humana's stock dropped 2.36% following the DOJ's announcement on May 1, 2025. 4. The lawsuit alleges illegal kickbacks related to Medicare Advantage enrollments from 2016-2021. 5. Investors are encouraged to join the class action against Humana.

3 mins saved
Full Article

FAQ

Why Bearish?

Humana's stock declined following serious allegations, indicating potential long-term risks similar to past fraud cases.

How important is it?

The legal investigation into Humana reflects serious risks that may deter investors, correlating with potential financial liabilities.

Why Short Term?

The immediate response to the DOJ announcement suggests rapid market reaction to legal issues.

Related Companies

CNCANTMAET
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Humana Inc.  (“Humana” or the “Company”) (NYSE: HUM).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Humana and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On May 1, 2025, the U.S. Department of Justice (“DOJ”) announced the filing of a False Claims Act complaint against several health insurance companies and insurance broker organizations, including Humana, “alleg[ing] that from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers’ Medicare Advantage plans.”  On news of the DOJ’s lawsuit, Humana’s stock price fell $6.20 per share, or 2.36%, to close at $256.04 per share on May 1, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.    CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News